When should a patient be referred to rheumatology?

When to Refer a Patient to Rheumatology

Refer patients with suspected inflammatory arthritis to a rheumatologist urgently—ideally within 6 weeks of symptom onset—as early specialist evaluation and treatment with disease-modifying antirheumatic drugs prevents irreversible joint damage in up to 90% of patients. 1

Immediate Urgent Referral Criteria

Refer urgently to rheumatology when any of the following are present:

• Small joints of the hands or feet are affected, as this is a common presentation of rheumatoid arthritis 1
• More than one joint is affected (polyarticular involvement), which increases the likelihood of inflammatory arthritis 1
• Three or more swollen joints are present, which is a strong indicator for early referral 2
• Metacarpophalangeal (MCP) or metatarsophalangeal (MTP) joint involvement is identified on examination 2
• Morning stiffness lasting ≥30 minutes to 1 hour, which is characteristic of inflammatory arthritis 1, 3
• Delay of 3 months or longer between symptom onset and seeking medical advice, as early treatment is crucial in preventing joint damage 1

Key Clinical Features to Assess Before Referral

Focus your examination on identifying definite synovitis, which is characterized by soft tissue swelling around joints (not bony enlargement):

• Assess for symmetric involvement of small joints, particularly MCP joints, proximal interphalangeal (PIP) joints, wrists, and MTP joints 1
• Look for difficulty making a fist, which is strongly associated with referral need (OR=3.67) 4
• Document if symptoms are most severe after midnight, which significantly increases likelihood of inflammatory arthritis (OR=6.29) 4
• Evaluate for wrist swelling and tenderness, both of which have high specificity for inflammatory arthritis 5
• Check for swelling of MCP joints 2 or 5, and PIP joints 2 or 3, as these have high predictive value 5

Essential Laboratory Testing Before Referral

Order the following tests to expedite rheumatology evaluation, but do not delay referral while awaiting results:

• Rheumatoid factor (RF), which has 70% specificity and moderate sensitivity for rheumatoid arthritis 1
• Anti-citrullinated protein antibodies (anti-CCP), which have 90% specificity and 60% sensitivity for rheumatoid arthritis 1
• C-reactive protein (CRP), which is preferred over ESR as it is more reliable and not age-dependent 1
• Erythrocyte sedimentation rate (ESR), which can be elevated in inflammatory arthritis 1
• Complete blood count with differential, comprehensive metabolic panel, and urinalysis as part of baseline assessment 3

Baseline Imaging to Obtain

• Obtain bilateral hand, wrist, and foot X-rays at initial presentation to assess for periarticular osteopenia, uniform joint space narrowing, and osseous erosions 1, 3

Three Categories of Rheumatology Referrals

Understanding the referral pattern helps prioritize urgency:

1. Patients with short-term regional pain syndromes (e.g., isolated shoulder pain, tennis elbow) that benefit from specific procedures—early treatment improves prognosis, so prompt access is important 6

2. Patients requiring diagnosis and counseling for chronic disorders like osteoarthritis, gout, fibromyalgia, or back pain that can be managed in the community with appropriate guidance 6

3. Patients with potentially progressive inflammatory conditions (inflammatory joint disease, autoimmune disorders) who require close supervision, early diagnosis and treatment, expert monitoring, and long-term multidisciplinary management to ensure optimal outcomes 6

Critical Pitfall to Avoid

Do not wait for laboratory results or imaging before making the referral. The decision to refer should be based primarily on clinical history and examination findings, not investigations 7. Only 26% of general practitioners refer suspected rheumatoid arthritis immediately without investigations, yet patient history and examination should have the greatest impact on referral decisions 7.

Symptomatic Treatment While Awaiting Rheumatology

• Initiate NSAIDs such as naproxen 500 mg twice daily at minimum effective dose for shortest time possible 1, 3
• Consider short-term glucocorticoids such as prednisone 5-10 mg daily as bridge therapy for temporary relief while awaiting DMARD effect 1, 3

Coordination of Care

• Schedule the rheumatology appointment before the patient leaves your office 1, 3
• Forward all laboratory results and imaging studies to the specialist 1, 3
• Educate the patient on the importance of urgent rheumatology follow-up within 6 weeks, expected symptoms, and smoking cessation 1, 3

Additional High-Risk Features

Consider referral even earlier when these prognostic factors are present:

• Loss of appetite in the context of joint symptoms 5
• Positive RF or anti-CCP antibodies 5
• Elevated acute phase reactants (CRP/ESR) 8
• Evidence of erosions on baseline radiographs 3